The Fragility Index Is Typically Misinterpreted and of Low Value: Clinical Trials Are Designed to Be Fragile.

MLA

Cote, Mark P., et al. “The Fragility Index Is Typically Misinterpreted and of Low Value: Clinical Trials Are Designed to Be Fragile.” Arthroscopy: The Journal of Arthroscopy & Related Surgery, vol. 40, no. 11, Nov. 2024, pp. 2635–37. EBSCOhost, https://doi.org/10.1016/j.arthro.2024.08.003.

APA

Cote, M. P., Lubowitz, J. H., Rossi, M. J., & Matzkin, E. (2024). The Fragility Index Is Typically Misinterpreted and of Low Value: Clinical Trials Are Designed to Be Fragile. Arthroscopy: The Journal of Arthroscopy & Related Surgery, 40(11), 2635–2637. https://doi.org/10.1016/j.arthro.2024.08.003

Chicago

Cote, Mark P., James H. Lubowitz, Michael J. Rossi, and Elizabeth Matzkin. 2024. “The Fragility Index Is Typically Misinterpreted and of Low Value: Clinical Trials Are Designed to Be Fragile.” Arthroscopy: The Journal of Arthroscopy & Related Surgery 40 (11): 2635–37. doi:10.1016/j.arthro.2024.08.003.